Effect of netazepide, a gastrin/CCK2receptor antagonist, on gastric acid secretion and rabeprazole-induced hypergastrinaemia in healthy subjects

Effect of repeated doses of netazepide, a gastrin receptor antagonist, omeprazole and placebo on 24 h gastric acidity and gastrin in healthy subjects

(2013) Malcolm Boyce et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Netazepide, a gastrin/CCK2receptor antagonist, causes dose-dependent, persistent inhibition of the responses to pentagastrin in healthy subjects

(2013) Malcolm Boyce et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Long-term, open-label trial: safety and efficacy of continuous maintenance treatment with pantoprazole for up to 15 years in severe acid-peptic disease

(2012) G. Brunner et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Single oral doses of netazepide (YF476), a gastrin receptor antagonist, cause dose-dependent, sustained increases in gastric pH compared with placebo and ranitidine in healthy subjects

(2012) M. Boyce et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Dyspeptic Symptom Development After Discontinuation of a Proton Pump Inhibitor: A Double-Blind Placebo-Controlled Trial

(2010) Anna Niklasson et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

In vivo analysis of mouse gastrin gene regulation in enhanced GFP-BAC transgenic mice

(2010) Shigeo Takaishi et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

The CCK2 receptor antagonist, YF476, inhibits Mastomys ECL cell hyperplasia and gastric carcinoid tumor development

(2010) M Kidd et al.   REGULATORY PEPTIDES

A meal test improves the specificity of chromogranin A as a marker of neuroendocrine neoplasia

(2010) Constantin S. Jianu et al.   TUMOR BIOLOGY

Proton-Pump Inhibitor Therapy Induces Acid-Related Symptoms in Healthy Volunteers After Withdrawal of Therapy

(2009) Christina Reimer et al.   GASTROENTEROLOGY

Control of Gastric Acid Secretion in Health and Disease

(2008) Mitchell L. Schubert et al.   GASTROENTEROLOGY